Introduction {#S1}
============

Breast milk harbors microbes that are potentially transferred to the neonate ([@B29]; [@B31]) and may influence the initial neonatal gut colonization and the maturation of the immune system ([@B18]). The composition of the human milk microbiota was shown to depend on mode of delivery, lactation time, gestational age and also geographical locations ([@B34]; [@B12]; [@B38]), the latter of which has not been confirmed by all studies ([@B41]).

Studies using cultivation-dependent techniques mainly isolated facultative anaerobes of the genera *Staphylococcus, Streptococcus, Lactococcus, Leuconostoc, Weissella, Enterococcus, Lactobacillus*, *Cutibacterium* (formerly *Propionibacterium*) and *Enterobacteriaceae* ([@B31]; [@B32]). The oxygen tolerance of bifidobacteria, which have also been isolated, varies between species ([@B3]). Accordingly, molecular techniques based on amplification of the 16S rRNA gene (quantitative PCR or 16S rRNA gene amplicon sequencing) indicated a high abundance of *Firmicutes* and *Proteobacteria*, and frequently recovered *Actinobacteria* ([@B64]; [@B46]). In addition, 16S rRNA gene amplicon sequencing suggested the presence of strict anaerobes of the orders *Clostridiales* and *Bacteroidales* in breast milk, albeit at low abundance ([@B15]; [@B32]; [@B47]; [@B46]). The presence of viable strict anaerobic gut microbes has, however, not been confirmed by cultivation ([@B32]). Several pathways have been suggested that explain the bacterial transfer to breast milk. Bacteria can enter milk from the skin of the mother or from the oral cavity of the infant. Another hypothesis is an active migration of gut bacteria to the mammary gland through an endogenous route ([@B31]). The isolation of identical strains of *Bifidobacterium* spp. in mother-infant pairs ([@B33]; [@B47]) supported this second pathway.

The World Health Organization recommends to exclusively breastfeed newborns up to 6 months post-partum ([@B66], [@B67]). Mature milk of term infants generally contains 67--78 g/L lactose, 32--36 g/L fat, and 9--12 g/L proteins. This composition seems to be conserved across populations ([@B4]) but concentrations vary between mothers and over lactational stages ([@B19]), diurnally and within one feeding ([@B25]; [@B28]), and outliers have been reported ([@B4]). The main carbohydrate in milk is lactose, HMO are the second most abundant carbohydrate source with concentrations of 10--20 g/L ([@B50]). HMO are composed of monosaccharides [D]{.smallcaps}-glucose, [D]{.smallcaps}-galactose, [L]{.smallcaps}-fucose, *N*-acetyl-[D]{.smallcaps}-glucosamine, and *N*-acetylneuraminic acid (also sialic acid). The most abundant secreted HMO include lacto-N-tetraose, lacto-*N*-neotetraose (LNnT), 2′fucosyllactose (2′FL), 3′fucosyllactose (3′FL), and the acidic HMO 3′sialyllactose (3′SL) and 6′sialyllactose (6′SL) ([@B40]; [@B22]). Breast milk provides essential amino and fatty acids, and long-chain polyunsaturated fatty acids. Lipids present in human milk cover 40--50% of the energy needs of the suckling infant ([@B69]). Beside these macronutrients, bioactive molecules such as secretory antibodies, immune cells, antimicrobial proteins like lactoferrin and lysozymes, and regulatory cytokines are part of human milk ([@B48]).

Breast milk is suckled by the infant, or is expressed by mechanic or electric breast pumps and frequently stored aerobically at 4 or −20°C before feeding ([@B54]), which may lead to degradation of some nutrients and milk microbes ([@B42]; [@B11]). These storage conditions would not allow the preservation of strict anaerobic bacteria. It was therefore the aim of this study to investigate microbiological stability during anaerobic milk storage with a focus on the cultivable microbiota. We tested the metabolism of the major sugars, lactose and HMO, as substrate carbohydrates for bacterial fermentation in breast milk and for the gut microbiota, resulting in the production of SCFA.

Materials and Methods {#S2}
=====================

Subjects and Sampling Conditions {#S2.SS1}
--------------------------------

A total of 21 breastfeeding women (27--40 years old) with infants aged 2.3--5.5 months were recruited in Switzerland. Exclusion criteria included the intake of antibiotics or probiotics within 1 month before the sampling day, chronic and acute diseases like fever, inflammation, diarrhea, and mastitis. Breast milk samples were collected from one breast lobe at one time point especially for this study. Written informed consent was obtained from the participants. The study protocol was approved by the Ethics Committee of the ETH Zurich (2018-N-14).

Prior collection, nipples and surroundings of one breast were cleaned using HibiScrub (Swissmedic, Switzerland) to reduce bacteria load on the skin. Milk samples (approximately 10--15 mL) were collected in a sterile flask wearing gloves and using an electrical pump (Medela, Switzerland). The first 3--5 ml were discarded. After expression, samples were immediately placed in an anaerobic jar (Oxoid AG, Switzerland) containing the Anaerocult A system (Merck, Switzerland) and transported to an anaerobic chamber (10% CO~2~, 5% H~2~, 85% N~2~, Coy Laboratories, United States). Samples were aliquoted for the different analyses or storage assays, half of the aliquots were used for immediate cultivation or were centrifuged at 14,000 × *g* for 20 min at 4°C. Cell pellets and supernatants were frozen at −20°C until further analysis. Other aliquots were transferred to an anaerobic jar containing the Anaerocult A system (Merck), were stored at 4°C for 6 days and then processed as described above (stored samples). The pH of fresh and stored milk samples was determined using a pH meter (Mettler-Toledo AG, Greifensee, Switzerland).

Cultivation Medium {#S2.SS2}
------------------

Columbia Broth (Becton Dickinson, Switzerland), which is a general medium used for the cultivation of fastidious bacteria was produced aerobically (Col_ae) according to the instructions of the supplier, or anaerobically (Col_an) to cultivate facultative anaerobes and strict anaerobes. Therefore, the Columbia powder was mixed with distilled water, boiled for 15 min, cooled down and flushed with CO~2~. [L]{.smallcaps}-cysteine (Sigma-Aldrich, Switzerland) was added when the temperature of the medium was approximately 50°C. Columbia broth was transferred to Hungate tubes flushed with CO~2~, tubes were sealed, and autoclaved. Yeast extract, casitone and fatty acid (YCFA) medium is used to cultivate gut microbes that depend on the presence of volatile fatty acids for growth ([@B16]; [Supplementary Table S1](#SM1){ref-type="supplementary-material"}). We adapted the composition of the fatty acid mix to acetate (70%), lactate (25%) and propionate (5%) to mimick the metabolite profile present in the infant gut ([@B51]). YCFA was prepared without added carbohydrate (YCFAwo) or with 18 g/l lactose (YCFA + Lact) or 2 g/l porcine mucin (YCFA + Muc). All components except L-cysteine-HCl were solubilized in deionized water, and the pH was adjusted to 7.6 with NaOH. The medium was flushed with CO~2~ and boiled. When the color changed from blue to pink, L-cysteine-HCl was added. The medium (10 ml) was transferred to Hungate tubes flushed with CO~2~, and tubes were sealed and autoclaved. Reinforced clostridial broth (RC; Sigma-Aldrich) and *Bacteroides* Mineral Salt Broth (BMS; [@B32]) were prepared in Hungate tubes according to instructions of the suppliers. Cultivation of lactic acid bacteria was carried out on agar plates with using modified de Man-Rogosa-Sharpe (mMRS) medium ([@B62]), with 1.5% agar (Difco). Modified Wilkins-Chalgren (mWC) agar plates containing 100 mg/l norfloxacin and 100 mg/l mupirocin were used to isolate *Bifidobacterium* spp. ([@B65]).

Cultivation Conditions for Viable Cells {#S2.SS3}
---------------------------------------

Cultivable cells were assessed in freshly expressed and stored breast milk using the most probable number (MPN) technique. A ten-replicate design ([@B63]) adapted to 96 well microtiter plates ([@B37]) was used. Milk samples were diluted with anaerobically prepared phosphate buffered saline (8 g/l NaCL, 200 mg/l KCl, 1.44 g/l Na~2~HPO~4~, 240 mg/l KH~2~PO~4~; pH 7.4) in tenfold dilution series. For each dilution, 180 μl of medium were supplied in microtiter plate (Bioswisstec AG, Switzerland) to which 20 μl of diluted sample were added. Microtiter plates were covered with a lid, and incubated at 37°C for 48 h inside the anaerobic chamber. For determination of MPN of aerobically grown cells, microtiter plates were prepared outside the anaerobic chamber and were incubated aerobically at 37°C for 48 h. Before and after incubation the optical density at 590 nm (OD~590~) was determined (Powerwave XS, BioTek). An increase in OD~590~ of ≥0.1 compared to the corresponding baseline was considered growth, and was confirmed visually. Based on these OD~590~ data, the MPN was calculated using the Excel Spread Sheet provided by the Food and Drug Administration (FDA, BAM^[1](#footnote1){ref-type="fn"}^). Following the OD~590~ measurement, 5 replicates of the 10^--1^ dilution were pooled and centrifuged at 13,000 × *g* for 15 min. Supernatants and pellets were kept at −20°C until further analysis. To determine the cultivable lactic acid bacteria and bifidobacteria, 100 or 200 μl of fresh or stored milk and ten-fold dilutions were spread on modified mMRS or mWC agar plates inside the anaerobic chamber in duplicates, and were incubated anaerobically for 2--4 days at 37°C.

To identify colonies from agar plates, DNA was isolated from liquid culture as described below, and the 16S rRNA gene was amplified using PCR and primers F8 (5′-AGA GTT TGA TCM TGG CTC-3′), and 1391R (5′-GAC GGG CGG TGT GTR CA-3′), both 10 μM, Microsynth, Switzerland). Amplicons were sent for Sanger sequencing to Eurofins Genomics (Germany). The resulting sequences were aligned against the 16S rRNA gene database provided by NCBI using blastN.

DNA Isolation {#S2.SS4}
-------------

Cell pellets obtained from fresh and stored breast milk samples and from bacterial cultures (1 ml) were thawed and the DNA extraction was done using Fast DNA SpinKit for Soil which includes a bead beating step (MP Biomedicals, France). DNA concentration was determined using QuBit and the dsDNA HS Assay Kit (Thermo Fisher), and ranged from 90 pg/ul to 39.3 ng/μl, whereas three samples were below detection limit (\<0.5 pg/μl) ([Supplementary Table S2](#SM1){ref-type="supplementary-material"}). DNA samples were stored at −20°C until further analysis.

Quantitative PCR (qPCR) {#S2.SS5}
-----------------------

Quantification of total bacteria and selected bacterial groups in milk samples before and after cold storage was performed using a Roche Light Cycler 480 ([Table 1](#T1){ref-type="table"}). Reactions contained 5 μl 2× SensiFASTSYBR (Labgene Scientific Instruments, Switzerland), 0.5 μl forward and reverse primer (each 10 μM; Microsynth), 3 μl MilliQ water, and 1 μl DNA. During the thermal cycling, the reaction mixtures were initially heated at 95°C for 3 min, followed by 40 cycles of denaturation at 95°C for 5 s, and annealing and extension at 60°C for 30 s. Melting curve analysis using a melting interval from 65 to 95°C was conducted to verify amplification specificity. All samples were analyzed in duplicates and in each run a standard curve out of a 10-fold dilution series of a linearized plasmid harboring the gene of interest was included. To correct for multiple 16S rRNA gene copies in one bacterial cell, gene copies were corrected for total bacteria, *Firmicutes*, *Bacteroidetes, Lactobacillus/Leuconostoc/Pediococcus* spp. (all correction factor 5) and *Veillonella* spp., *Clostridium* cluster IV (both correction factor 4) and XIVa (correction factor 6) ([@B61]).

###### 

Targets and primers used in qPCR reactions.

  **Bacterial phylum**   **Target genes**                                             **Primer**          **5**′**-3**′                                 **References**
  ---------------------- ------------------------------------------------------------ ------------------- --------------------------------------------- ----------------
  \-                     Total bacteria 16S rRNA gene                                 Eub338F             ACWCCTACGGGWGGCAGCAG                          [@B26]
                                                                                      Eub518R             ATTACCGCGGCTGCTGG                             
  *Firmicutes*           *Firmicutes* 16S rRNA gene                                   Firm934F            GGAGYATGTGGTTTAATTCGAAGCA                     [@B26]
                                                                                      Firm1060R           AGCTGACGACAACCATGCAC                          
                         *Clostridium* cluster IV 16S rRNA gene                       Clep866mF           TTAACACAATAAGTWATCCACCTGG                     
                                                                                      Clept1240mR         ACCTTCCTCCGTTTTGTCAAC                         [@B53]
                         *Clostridium* cluster XIVa 16S rRNA gene                     g.Ccoc-F g-Ccoc-R   AAATGACGGTACCTGACTAA CTTTGAGTTTCATTCTTGCGAA   [@B45]
                         *Veillonella* spp. 16S rRNA gene                             Vspp - F            AYCAACCTGCCCTTCAGA                            [@B52]
                                                                                      Vspp - R            CGTCCCGATTAACAGAGCTT                          
                         *Lactobacillus/Pediococcus/Leuconostoc* 16S rRNA gene        F_Lacto 05          AGCAGTAGGGAATCTTCCA                           [@B21]
                                                                                      R_Lacto 04          CGCCACTGGTGTTCYTCCATATA                       
                         *Streptococcus* spp. *tuf*                                   Tuf-Strep-1         GAAGAATTGCTTGAATTGGTTGAA                      [@B15]
                                                                                      Tuf-Strep-R         GGACGGTAGTTGTTGAAGAATGG                       
                         *Staphylococcus* spp. *tuf*                                  T-Stag422           GGCCGTGTTGAACGTGGTCAAATCA                     [@B44]
                                                                                      TStag765            TYACCATTTCAGTACCTCTGGTAA                      
  *Bacteroidetes*        *Bacteroides/Prevotella/Porphyromonas* group 16S rRNA gene   Bac303F             GAAGTCCCCCACATTG                              [@B53]
                                                                                      Bfr-Femrev          CGCKACTTGGCTGGTTCAG                           
  *Proteobacteria*       *Enterobacteriaceae* 16S rRNA gene                           Eco1457F            CATTGACGTTACCCGCAGAAGAAGC                     [@B5]
                                                                                      Eco1652R            CTCTACGAGACTCAAGCTTGC                         
  *Actinobacteria*       *Bifidobacteria* 16S rRNA gene                               Bif F               TCGCGT CYGGTGTGAAAG                           [@B55]
                                                                                      Bif R               CCACATCCAGCRTCCAC                             
                         *Propionibacterium*/*Cutibacterium* spp. 16S rRNA gene       Avi Fwd             GTCTGCAACTCGACCCCAT                           [@B56]
                                                                                      Avi Probe           CTTCGACGGCTCCCCCACACAGGT                      

16S rRNA Gene Library Preparation and Sequencing {#S2.SS6}
------------------------------------------------

Libraries covering the V3 region of the 16S rRNA gene were prepared using a two-step PCR approach. In the first reaction, 100 ng DNA was used as template and was amplified with 12 μl AccuPrime SupermixII (Life Technologies Europe BV, Switzerland), 0.5 μl of with barcoded primers NXt_338F (5′-TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG ACW CCT ACG GGW GGC AGC AG-3′) and NXt_518R (5-′GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GAT TAC CGC GGC TGC TGG-3′; Microsynth, both 10 μM) and water to a final volume of 25 μl. Thermocycling was conducted as follows: initial denaturation at 95°C for 2 min, 25 cycles of denaturation at 95°C for 15 s, annealing at 55°C for 15 s and extension at 68°C for 30 s followed by final extension at 68°C for 4 min.

To add adapters and indexes, a second PCR was performed using 12 μl of AccuPrime Pfx Fusion mix (Thermo Fisher), 2 μl of corresponding P5 and P7 primer (Nextera Index Kit, Illumina, United States), 2 μl of the PCR product from the first PCR and nuclease-free water to a final volume of 25 μl. The PCR temperature profile was as follows: 98°C for 1 min, followed by 12 cycles of: 95°C for 15 s, 55°C for 20s and 72°C for 20 s and a final extension step at 72°C for 5 min. The amplified fragments were purified using AMPure XP beads (Beckman Coulter Genomic, United States) according to manufacturer's manual. Prior to pooling, libraries were quantified using a Qubit fluorometer (Thermo Fisher) and were mixed in approximately equal concentrations.

Due to low concentration of DNA in most milk samples ([Supplementary Table S2](#SM1){ref-type="supplementary-material"}), low efficiency of the barcoded degenerated primers used for amplicon sequencing, and the likely presence of contaminating eukaryotic DNA, the standard sequencing protocol had to be adapted to a nested PCR approach, similar as previously employed for breast milk or other samples from environments with low bacterial load ([@B68]; [@B8]; [@B35]). For the optimized protocol, the V3 hypervariable 16S rRNA gene region of selected milk samples was preamplified with primers 338F (10 μM) and 518R (10 μM) as described above, using 5 μl of milk DNA as template. Purified PCR products (WizardSV Gel and PCR Clean-Up System, Promega, Switzerland) were then used for the barcoding PCR.

Sequencing was carried out on an Illumina MiSeq at the Genetic Diversity Center of ETH Zurich. Preparation of the library used the V2 2 × 250 bp paired end NextTera chemistry supplemented with 30% of PhiX. Raw sequencing reads were processed by merging the paired reads using USEARCH (v8.1.1756) with to a minimum length of 100 bp setting the expected error threshold to 1 and the minimum overlapping to 15 bp. Raw sequencing reads were filtered using PRINSEQ-lite (v0.20.4). Sequences that passed quality filtering were clustered into OUTs at 97% identity level using UPARSE (usearch v8.0.1623). Representative sequences were aligned using PyNAST (QIIME-1.8.0) and taxonomically assigned using UTAX (usearch v8.1.1756). Sequencing of MPN samples (*n* = 12) yielded 584,096 reads (mean 48,675 reads/sample), sequencing of milk samples (*n* = 6) yielded 148,590 reads (mean 24,765 reads/sample).

Lactose, Lactate and SCFA Determination {#S2.SS7}
---------------------------------------

The supernatants from fresh and stored milk, and from randomly selected MPN milk samples were subjected to high performance liquid chromatography (Merck-Hitachi, Switzerland) with refractive index detection (HPLC-RI) using an Aminex HPX-87H column (300 × 7.8 mm; BioRad, Switzerland). Thawed supernatants (40 μl) were, without additional extraction procedure, eluted at 40°C with 10 mM H~2~SO~4~ at a flow rate of 0.6 ml per minute. Lactose, SCFA and lactate were quantified using external standard (all from Sigma-Aldrich). Detection limits were 1 mM for lactose, 0.9 mM for lactate, and 0.5 mM for formate, succinate, acetate, propionate and butyrate. A representative chromatogram is shown in [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}.

Qualitative Analysis of HMO Composition of Fresh and Stored Milk {#S2.SS8}
----------------------------------------------------------------

HMO profiles before and after milk storage were qualitatively analyzed using high pH anion exchange chromatography with amperometric detection (HPAEC-PAD) on a Dionex IC3000 equipped with a CarbopacPA20 column (Thermo Fisher) and an electrochemical detector with a gold electrode. HMO were analysed directly from milk supernatants without further extraction procedure. Water (A), 200 mM NaOH (B) and 1 M Na-acetate (C) were used as solvents at a flow rate of 0.25 ml/min with the following gradient: 0 min 30.4% B, 1.3% C, 22 min 30.4% B, 11.34% C, followed by washing and regeneration. Main HMO were identified using 2′FL, 3′FL, 3′SL, 6′SL, lacto-*N*-neotetraose, *N*-acetylneuraminic acid supplied by Glycom A/S (Denmark) as external standards.

Statistical Analysis {#S2.SS9}
--------------------

Differences in log viable counts between fresh and stored samples, and between cultivation media were tested using paired two-tailed *t*-test or Kruskal Wallis One Way Analysis of Variance of Ranks with Dunn's method for pairwise comparison (SigmaPlot 13), respectively. Differences between cell counts in fresh and stored samples determined using qPCR were evaluated using the paired two-tailed *t*-test. The degree of correlations between parameters and their significance was tested using IBM SPSS Statistics 20.0 (IBM SPSS Inc., Chicago, IL, USA). Significance was set at *p* \< 0.05.

Data Availability {#S2.SS10}
-----------------

16S rRNA gene sequences are available at ncbi's sra archive under bioproject accession number [PRJNA557136](PRJNA557136).

Results {#S3}
=======

Cultivable Bacteria in Fresh and Stored Human Breast Milk Samples {#S3.SS1}
-----------------------------------------------------------------

The viable cell counts in fresh and cold stored breast milk were assessed using a cultivation-based approach combining MPN technique and cultivation on agar plates with different semi- and non-selective media. Significant higher mean cell counts in fresh breast milk were obtained in YCFA containing either mucin or lactose (YCFA + Muc: log 4.2 ± 1.8 cells/ml, YCFA + Lact: log 3.9 ± 1.4 cells/ml), or aerobic (log 3.2 ± 0.7 cells/ml) and anaerobic (log 3.0 ± 0.7 cells/ml) Columbia medium compared to the other media tested ([Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). The addition of lactose and mucin led to significantly higher cell counts compared to YCFAwo (log 2.5 ± 0.8 cells/ml). Lactic acid bacteria viable counts on mMRS agar plates were log 2.3 ± 1.3 CFU/ml in fresh samples ([Figure 1](#F1){ref-type="fig"}). Representative isolates obtained from the undiluted samples were identified as *Enterococcus* and *Streptococcus* spp., and *Cutibacterium acnes*. No growth was observed on mWC agar plates used to detect bifidobacteria.

###### 

Mean viable cell counts in fresh and anaerobic milk samples.

  **Medium**   **mMRS**         **mWC**   **Columbia aerobic**   **Columbia anaerobic**   **YCFAwo**           **YCFA + Muc**   **YCFA + Lac**   **BMS**          **RC**
  ------------ ---------------- --------- ---------------------- ------------------------ -------------------- ---------------- ---------------- ---------------- ----------------
  Fresh        2.3 ± 1.3^b,A^   nd^1^     3.2 ± 0.7^a,A^         3.0 ± 0.7^a,A^           2.5 ± 0.8^b,A^       4.2 ± 1.8^a,A^   3.9 ± 1.4^a,A^   2.7 ± 1.0^b,A^   2.5 ± 0.8^b,A^
  Stored       2.1 ± 1.4^b,A^   nd        2.9 ± 1.0^b,A^         3.0 ± 0.8^b,A^           3.2 ± 1.0^*b,\ B*^   4.6 ± 1.4^a,A^   4.3 ± 1.5^a,A^   3.3 ± 1.9^a,A^   2.4 ± 1.0^b,A^

Mean viable cell counts in fresh and anaerobically stored (6 days at 4°C) breast milk samples (

n

= 21) were determined by MPN or plate counts using different cultivation media.

1

nd, not detected.

a,b

Mean viable cell counts of different cultivation media fresh or stored samples sharing the same small letter did not significantly differ.

A,B

Mean viable cell counts fresh and stored samples determined in one media type sharing the same capital letter did not significantly differ.

![Bacterial load in fresh breast milk investigated by cultivation or quantitative PCR. Boxes indicate the 25th and 75th percentiles. Whiskers indicate 10th and 90th percentiles, 5th and 95th percentiles are shown as dots. The dotted and solid lines indicate mean and median, respectively. (Viable) cell counts of individual samples are indicated by black dots.](fmicb-10-02666-g001){#F1}

During storage, mean cell counts significantly increased in YCFAwo (*p* \< 0.05, Δlog 0.6 ± 0.8 cells/ml) compared to fresh milk samples, but no significant change was measured for the other cultivation conditions ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"} and [Table 2](#T2){ref-type="table"}). No significant correlations were detected for viable cell concentrations among the different culture conditions, suggesting that each cultivation medium supported different groups of bacteria, with the exception of cell counts in YCFA + Muc and YCFA + Lact which positively correlated (*r* = 0.385; *p* \< 0.05).

After grouping data for infants according to age (≤3 months, average 2.8 ± 0.4 months, *n* = 9; and \>3 months, average 4.8 ± 0.6 months, *n* = 12), log MPN were significantly higher for stored samples tested in anaerobic Columbia Broth (≤3 months: log 2.6 ± 0.7 cells/ml, \>3 months: log 3.2 ± 0.6 log/ml; *p* \< 0.05) and in YCFA + Lact (≤3 months: log 5.1 ± 1.4 log cells/ml, \>3 months: 4.0 ± 1.2 log cells/ml; *p* \< 0.05). No group difference was detected for other media and for fresh samples in all media. Age of the infants negatively correlated with fresh milk bacterial cell counts in RC (*r*: −0.54, *p* \< 0.05), and mMRS (*r*: −0.46, *p* = 0.037) and YCFA + Lact (*r*: −0.47, *p* \< 0.05), and positively with bacterial load in Col_an (*r*: 0.64 *p* = 0.034) of stored samples. The age of the mother was negatively correlated with log MPN after cold storage in RC medium (*r*: −0.54; *p* = 0.013).

Bacterial Composition and Production of SCFA and Lactate During the Cultivation in Different Media {#S3.SS2}
--------------------------------------------------------------------------------------------------

Supernatants of selected samples grown in YCFAwo, and YCFA + Muc were analyzed by HPLC-RI to investigate the formation of SCFA. In YCFAwo (*n* = 6 samples analyzed), formation of acetate (42.4 ± 8.7 mM), lactate (11.9 ± 1.4 mM) and propionate (2.3 ± 0.4) was detected in 5/6 samples. In YCFA + Muc in 6/12 samples from day 0, lactate (7.9--68.2 mM), acetate (3.4--13.2 mM) and formate (3.1--7.3 mM) were formed, propionate was detected in one sample (12.1 mM). In two samples, this metabolic profile differed at day 6 with lactate utilization (−5.7 to −6.9 mM) observed while the other three samples showed reduced lactate and/or acetate formation. In four fresh milk samples, lactate was used (−6.0 to −11.2 mM) and acetate was formed (6.2--19.3 mM) with little difference between day 0 and day 6. For one sample, metabolic activity (lactate formation and acetate utilization) was only observed at day 0, while for one sample there was little metabolic activity at both sampling days.

We also determined the 16S rRNA gene composition of selected MPN samples in overnight cultures of the −1 dilutions with total cell counts ranging from log 2.8--7.3 cells/mL ([Figure 2](#F2){ref-type="fig"}). Unclassified *Bacillaceae*, *Bacillus*, and *Staphylococcus* were the most abundant taxa contributing \>95% of the reads. *Bifidobacterium* were present in all analyzed samples at \<0.6% relative abundance. Strict anaerobes of the *Clostridiales* and the *Bacteroidales* were recovered at around 0.35 and 0.01%, respectively. The alpha-diversity within each sample was low as estimated using the number of observed OTUs, Shannon diversity and Chao1 index as measures. The number of observed OTUs (12--23) correlated positively with MPN of the sample (*p* \< 0.05). The Shannon index, which equally weighs richness and evenness, ranged from 0.01 to 0.67, while Chao1 indices ranged from 10 to 42.

![Relative abundance of bacterial taxa in selected MPN samples. Samples were collected from 10 fold dilutions of fresh and stored milk samples grown for 24 h at 37°C in MPN assays conducted in different media. The MPN of these samples ranged from log 2.8 cells/mL to log 6.3 cells/mL). Microbiota composition was determined using 16S rRNA gene amplicon sequencing.](fmicb-10-02666-g002){#F2}

Abundance and Diversity of Bacterial Population of Fresh and Stored Breast Milk {#S3.SS3}
-------------------------------------------------------------------------------

Breast milk samples (*n* = 19) were analyzed by qPCR to estimate cell counts of total bacteria and of selected bacterial groups representing the predominant phyla *Firmicutes*, *Bacteroidetes*, *Actinobacteria*, and *Proteobacteria* in fresh and stored milk, using correction for multiple 16S rRNA gene copies per cell. Fresh and stored milk samples contained an average of total bacteria of log 5.4 ± 0.5 cells/ml ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}). Only limited changes in total bacteria were observed with a maximum two-fold increase of samples 8, 9, and 10 (Δlog 0.3 cells/ml breast milk), while highest overall decrease was detected in samples 5, 18, 20, and 21 (Δlog −0.4 cells/ml breast milk) ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}).

![Bacterial populations in fresh and stored breast milk samples. The abundance of total bacteria and of selected bacterial groups commonly present in breast milk was determined by qPCR. Boxes indicate the 25th and 75th percentiles. Whiskers indicate 10th and 90th percentiles, 5th and 95th percentiles are shown as dots. The dotted and solid lines indicate mean and median, respectively. Cell counts of individual samples and changes in abundance during storage are indicated by black dots and connecting lines.](fmicb-10-02666-g003){#F3}

In fresh milk, the most prevalent phylum was *Firmicutes* contributing the majority of cells (85%) in all samples. *Streptococcus* spp*., Lactobacillus/Leuconostoc/Pediococcus* spp. and *Veillonella* spp. were present in 79, 63, and 53% of the fresh samples, respectively ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}), while *Staphylococcus* spp., *Clostridium* clusters IV and XIVa were only detected in 26% of the samples. Mean cell counts of these major bacterial groups did not significantly change during storage ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}). *Enterobacteriaceae* (phylum *Proteobacteria*) were detected in 68 and 58% of the samples before and after storage, respectively, at low abundance. *Propionibacterium/Cutibacterium* spp. was detected in 5 and 16% of the samples before and after storage, respectively, and *Bifidobacterium* 16S rRNA genes (both phylum *Actinobacteria*) could not be amplified in any sample. After storage, the prevalence of *Bacteroides/Prevotella/Porphyromonas* group was threefold increased from 16 to 47% ([Figure 3](#F3){ref-type="fig"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}). There was no change in prevalence and abundance of *Clostridium* cluster XIVa while the abundance of *Clostridium* cluster IV significantly increased ([Supplementary Table S3](#SM1){ref-type="supplementary-material"}).

To investigate bacterial diversity, we tested 16S rRNA gene amplicon sequencing. As the standard protocol did not yield and PCR products, we employed a nested PCR approach. Visible bands after the initial and the 1st PCR were obtained for samples that contained \>2 ng/μL DNA, or \>log 6 cells/ml, which corresponded to only six samples in total. However, this approach yielded a high proportion (13--70%) of unclassified reads even at phylum level ([Supplementary Figure S3](#SM1){ref-type="supplementary-material"}) indicating unspecific overamplification. The most abundant assigned phyla were *Firmicutes* (*Streptococcaceae, Staphylococcaceae, Peptostreptococcaceae*, and *Erysipelotrichaceae*) and *Proteobacteria* (*Burkholderiaceae, Comamonadaceae*, and *Oxalabacteraceae*), and at lower relative abundance *Actinobacteria* (*Bifidobacteriaceae*).

Impact of Storage on Lactose, Human Milk Oligosaccharide and SCFA Profile of Breast Milk {#S3.SS4}
----------------------------------------------------------------------------------------

Breast milk samples were analyzed by HPLC-RI to determine the concentrations of lactose, SCFA and lactate. The average lactose content in fresh milk samples was not impacted by milk storage, with 161.8--235.8 mM and 156.3--227.6 mM in fresh and stored milk, respectively ([Table 3](#T3){ref-type="table"}). Lactose content decreased in 9 stored milk samples (−43.8 to −5.2 mM) but increased in 11 samples (+ 1.8--15.8 mM), respectively ([Table 3](#T3){ref-type="table"}). Lactate was detected after anaerobic cold storage in 18/21 samples at concentrations, ranging from 2.3 to 18 mM, but was not present in fresh milks. Lactate concentration in stored milks negatively correlated with the change of pH during storage (from −1.4 to 0 pH unit); *r*: −0.529, *p* = 0.016) but was not correlated with the lactose concentration change. Free butyrate was detected in 15/21 and 18/21 samples before and after storage, respectively, at concentrations in the range from 2.5 to 5.7 mM. Acetate, propionate or formate were not present in detectable amounts in any sample.

###### 

Lactose, lactate, and butyrate concentration and pH in fresh and stored breast milk samples.

  **ID**   **Sugar or metabolite concentration (mM)**   **pH**                                                                    
  -------- -------------------------------------------- -------- --------- ---- ------ --------- ----- ----- -------- ----- ----- --------
  2        235.8                                        na       nd        nd   3.1    \+ 3.1    nd    nd    --       7.0   6.4   −0.6
  3        214.7                                        209.5    −5.2      nd   18.0   \+ 18.0   nd    5.7   \+ 5.7   na    na    na
  4        257.1                                        213.3    −43.8     nd   7.0    \+ 7.0    5.3   5.1   −0.2     6.8   6.3   −0.5
  5        227.6                                        212.7    −14.9     nd   2.7    \+ 2.7    nd    5.7   \+ 5.7   6.7   6.4   −0.3
  6        201.3                                        206.5    \+ 5.2    nd   nd     --        5.7   5.5   −0.2     6.9   6.7   −0.2
  7        231.1                                        260.0    \+ 28.9   nd   3.6    \+ 3.6    4.8   4.6   −0.2     6.8   6.7   −0.1
  8        200.7                                        206.8    \+ 6.1    nd   5.8    \+ 5.8    4.6   3.9   −0.7     6.7   6.5   −0.2
  9        205.4                                        217.4    \+ 12.0   nd   7.6    \+ 7.6    4.4   4.6   −0.2     7.1   6.5   −0.6
  10       222.3                                        213.6    −8.8      nd   5.6    \+ 5.6    4.1   3.9   −0.2     7.3   6.6   −0.7
  11       223.2                                        224.9    \+ 1.8    nd   8.1    \+ 8.1    4.6   3.7   −0.9     6.7   6.3   −0.4
  12       207.7                                        216.2    \+ 8.5    nd   6.7    \+ 6.7    3.9   4.4   \+ 0.5   7.7   6.3   −1.4
  13       231.7                                        231.7    0         nd   nd     nd        3.9   4.1   \+ 0.2   7.0   7.0   0
  14       209.5                                        220.6    \+ 11.1   nd   5.4    \+ 5.4    3.7   3.2   −0.5     7.6   6.4   −1.2
  15       204.5                                        192.8    −11.7     nd   5.6    \+ 5.6    3.4   3.4   0        7.2   6.3   −0.9
  16       198.9                                        191.9    −7.0      nd   7.4    \+ 7.4    3.2   3.0   −0.2     7.3   6.4   −0.9
  17       217.6                                        220.0    \+ 2.3    nd   2.3    \+ 2.3    2.8   3.2   \+ 0.4   7.2   6.6   −0.6
  18       176.5                                        192.2    \+ 15.8   nd   6.3    \+ 6.3    3.0   2.5   −0.5     7.2   6.1   −1.1
  19       208.6                                        214.1    \+ 5.6    nd   5.2    \+ 5.2    nd    2.5   \+ 2.5   7.1   6.3   −0.8
  20       212.1                                        223.5    \+ 11.4   nd   2.3    \+ 2.3    2.5   nd    −2.5     6.7   6.8   \+ 0.1
  21       213.6                                        229.3    \+ 15.8   nd   6.1    \+ 6.1    nd    nd    --       7.3   6.5   −0.8
  22       161.8                                        156.3    −5.6      nd   nd     nd        nd    2.8   2.8      7.4   7.0   −0.4

Lactose, lactate and butyrate concentration in fresh and stored samples from 21 mothers was measured by HPLC-RI. nd: not detectable; na: not available

HMO profiles were generated from fresh and stored breast milk samples using HPAEC-PAD ([Figure 4](#F4){ref-type="fig"}). The major HMOs 3′FL, 3′SL, 6′SL were detected in all samples. 2′FL could not be analyzed due to similar retention time as lactose, LNnT appeared as a shoulder of the lactose peak. There was no change in HMO profiles, no visible release of fucose or sialic acid (*N*-acetylneuraminic acid), and no accumulation of glucose or galactose, indicating that at least the most prevalent and abundant HMO were not degraded during storage.

![HMO profiles before and after storage. Shown are representative profiles generated from fresh (bold line) and stored (dotted line) samples 12 and 13. Major HMO were identified using external standards.](fmicb-10-02666-g004){#F4}

Discussion {#S4}
==========

Human breast milk banks usually store samples aerobically at −20°C to minimize or prevent biological and chemical degradation, after batchwise pasteurization is performed ([@B27]). These treatments likely inactivate a large fraction of the non-spore forming microbes present in fresh milk. Indeed, previous studies observed different impact of freezing on microbiota composition ([@B43]; [@B1]). In this study, we first investigated the microbial population in fresh milk, using a combination of cultivation-dependent and cultivation-independent methods, and also determined the impact of 6-day storage at 4°C. Samples were stored under anaerobic conditions as common domestic procedures for refrigerated storage at 4°C or freezing at − 20°C likely result in oxygenation of milk, depending on the handling and packaging. These conditions may hinder the delivery of natural mother's milk microbes, especially strict anaerobes, which may play a role in the colonization of the neonate gut.

Total Bacterial Load in Mature Human Breast Milk {#S4.SS1}
------------------------------------------------

The total viable bacteria counts in breast milk determined using plate counts were reported in the range from 1.2 to 5.5 log CFU/ml in breast milk of South African mothers (*n* = 55) ([@B23]), between log 2 and 6 in mothers own milk (*n* = 12) from preterm infants ([@B13]) and \<log 4.4 CFU/ml in milk from Swiss mothers (*n* = 7) ([@B32]). In agreement, our data confirmed that the number of bacterial cells recovered depended on the type of cultivation medium used and on culture conditions. In this study we applied the MPN method under strict anaerobic conditions and YCFA, a medium developed for the cultivation of gut microbes ([@B16]). We supplied mucin or lactose, which are major carbohydrates available to breast milk and gut microbes, to the growth media, and also added acetate, propionate, and lactate in a ratio that mimicked metabolite profiles determined in infant feces ([@B51]). Bacterial cell counts determined in strict anaerobically prepared YCFA were higher in several samples than for a routinely used standard medium such as Columbia broth suggesting adapted YCFA broth as a suitable medium to recover a wide range of human milk microbes by cultivation.

Varying values were reported for the total bacterial load in human breast milk depending on the methodology applied. Quantification of 16S rRNA gene sequences suggested a bacterial load of up 10^6--7^ cells/ml of milk after correcting for multiple 16S rRNA gene copies per cell ([@B15]; [@B8]), which is on average around log 1 cells/ml higher than tested with cultivation-based ([@B23]; [@B32]). This may be explained by incomplete recovery of all viable microbes by culture and/or by detection of 16S rRNA material from dead or lysed cells. During cultivation bacteria may grow directly on the sugar source present in the medium, or on intermediate metabolites produced by other microbes in cross-feeding. For e.g., only a minority of specialist microbes is adapted to degrade the complex mucin polymers and nevertheless we obtained high cell counts when mucin was provided as sole carbohydrate source. We also showed before that infant gut microbes can form trophic networks from mucin to yield SCFA ([@B58]; [@B10]).

Diversity of Breast Milk Microbes {#S4.SS2}
---------------------------------

Using a combined culture-dependent and -independent approach, we observed differently prevalent and abundant microbial subpopulations in the breast milk samples indicating high inter-individual variability of breast milk microbiota, akin to infant fecal microbiota ([@B51]). Our data are in agreement with previous culture-independent studies using 16S rRNA gene amplicon sequencing identifying a range of mainly members of the *Firmicutes* and *Proteobacteria* at proportions differing among individuals and studies ([@B8]; [@B57]; [@B64]; [@B41]; [@B59]). We also attempted to determine microbiota composition using 16S rRNA amplicon sequencing. However, as similarly reported by [@B57], and [@B59], the first PCR failed to yield a quantifiable PCR product, likely the bacterial load in milk samples was at or below the limit of log 6 copies/ml ([@B6]). Some samples were nevertheless sequenced, but did not yield sufficient reads. We then tested a nested PCR approach similar to [@B8] to first enrich the target amplicon, however, this approach yielded a high proportion (13--70%) of unclassified reads even at phylum likely due to low initial cell numbers and overamplification due to the nested PCR approach.

Major Viable Bacterial Populations in Breast Milk Samples {#S4.SS3}
---------------------------------------------------------

To our surprise, we neither cultivated any *Bifidobacterium* nor amplified *Bifidobacterium* 16S rRNA genes using qPCR from fresh and stored breast milk samples while low abundant populations were detected in MPN samples using 16S rRNA gene sequencing. Previous studies reported the isolation of bifidobacteria ([@B43]; [@B60]; [@B32]; [@B36]; [@B47]). However, isolation frequency varied between 6 and 35% of the donors ([@B43]: 8/23; [@B23]: 6/55; [@B32]: 1/7; [@B47]:1/10; [@B57]: 5/90). *Bifidobacterium* were also not detected in breast milk when metagenomics was employed ([@B49]), suggesting that *Bifidobacterium* spp. are a variable component of the human breast milk microbiota, or that they cannot be readily detected by the applied methods. *Bifidobacterium* spp. were suggested to be indicator organism providing evidence for the existence of an entero-mammary pathway as identical strains have been isolated from mother-infant pairs ([@B33]; [@B47]).

Culture independent 16S rRNA gene analysis frequently ([@B32]; [@B8]; [@B64]; [@B41]) but not always ([@B57]; [@B59]) suggests the presence of strict anaerobes of the *Clostridiales*, and *Bacteroidetes* in breast milk samples, however, isolates have not been obtained yet. In agreement, we also recovered 16S rRNA genes of *Clostridiales* and *Bacteroidetes* in fresh and stored milk. After anaerobic storage the prevalence of *Bacteroidetes* increased 3-fold while *Clostridium* clusters IV and XIVa of the *Clostridiales* increased in abundance or became detectable in seven samples, indicating that (1) viable strict anaerobes were present in breast milk albeit at low abundance, and that (2) anaerobic storage of breast milk at 4°C promoted the growth of some strict anaerobes.

(Unclassified) *Bacillaceae* were a major viable bacterial population recovered in MPN samples in agreement with *Firmicutes* being the major phylum present in breast milk according to qPCR analysis. The presence of *Bacillus* spp. in breast milk was observed before ([@B38]; [@B64]; [@B13]; [@B59]).

Using cultivation, we recovered *S. epidermis, Streptococcus* spp. and *C. acnes* from mMRS agar plates which belong to the natural skin microbiota ([@B24]). These species were already isolated by other researchers and are considered milk microbes ([@B15]; [@B30]; [@B32]).

Major HMO Composition Is Maintained After Storage Despite Bacterial Metabolic Activity {#S4.SS4}
--------------------------------------------------------------------------------------

Lactose and HMO are major carbohydrates of breast milk constitute an important source of nutrients for the infant and the gut microbiota. Because of their resistance to enzymatic hydrolysis in the intestine, HMO represent the first prebiotic ingested ([@B17]). Certain species of infant gut microbes such as *Bifidobacterium longum* subsp. *infantis* or *Bifidobacterium bifidum* are able to degrade and metabolize HMO ([@B22]; [@B58]); HMO also directly interact with pathogens ([@B7]; [@B39]; [@B47]). Our study shows that anaerobic cold storage of human milk for up to 6 days efficiently control both bacterial growth and degradation of HMO. HMO composition had been shown to vary among women, and depend on period of lactation and on the expression of specific glycosyltransferases in the mammary glands ([@B39]) and also in this study the HMO profiles differed between donors. Lactose concentrations exhibited changes during storage, either decreasing or increasing depending on the milk sample. An apparent increase of lactose content during storage of human milk was also reported by [@B14]. Anaerobic cold storage of the milk did not significantly impact major HMO content and total bacterial load of human milk samples but led to changes in abundance of main bacterial groups. Milk does not contain oxygen until it is expressed from the mammary gland and comes in contact with air. Collection and home storage of milk may introduce oxygen in the milk, depending on the collection and storage container, which may affect the growth and viability of oxygen-sensitive bacteria.

Butyrate Is a Component of Fresh Breast Milk {#S4.SS5}
--------------------------------------------

The majority of breast milk samples contained the SCFA butyrate which is in agreement with previous reports ([@B9]; [@B2]). Human milk fat, which is mainly composed of triglycerides, contains less butyrate than cow milk (0.4 versus 2--3% by weight, respectively) ([@B9]). Free butyrate concentrations remained stable during storage or even slightly increased due to degradation of lipids. The later may be due to the activity of milk lipases during cold storage ([@B20]) and possibly by the activity of butyrate producers despite being present at low abundance.

Conclusion {#S5}
==========

Our results indicate the presence of viable strict anaerobes such as *Bacteroidetes* and *Clostridum* clusters IV and XIVa. YCFA supplemented with mucin or lactose was identified a suitable medium to recover a wide range of breast milk microbes by cultivation. Anaerobic cold storage of the milk, albeit at the moment not routinely used for preservation, did not significantly impact major HMO content and total bacterial load of human milk samples but led to changes in abundance of main bacterial groups.
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